Company
An outpost of global open innovation,
JW Theriac
Strengthening networks with global bio clusters based on JW's R&D technology, Innovative new drug pipeline expansion
-
Establishment of a global bio cluster network
Established in 2001, JW Theriac is a specialized research subsidiary of JW Pharmaceutical and is located in Boston, USA.
JW, a comprehensive healthcare company, includes JW Pharmaceutical Drug Discovery Center, C&C Research Laboratories, and JW Bioscience.
We are conducting R&D equipped with specialized research facilities in each field Oncology, Immunology, Regenerative Medicine . -
Expansion of innovative new drug pipeline using
JW R&D platformJW Theriac focuses on global open innovation activities, creating a new platform that can create synergy with JW's pipeline.
We are preparing research collaboration and cooperation plans with target-oriented innovative companies.
Based on over 20 years of know-how and experience, we are leading cooperation on innovative new drug development programs.